- Home
- BBIO vs CCK Comparison
BBIO vs CCK Comparison
Compare BBIO & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | CCK |
|---|---|---|
| Founded | 2015 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.5B |
| IPO Year | 2019 | 2003 |
Fundamental Metrics
Financial Performance| Metric | BBIO | CCK |
|---|---|---|
| Price | $67.48 | $92.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 16 |
| Target Price | $86.33 | ★ $121.19 |
| AVG Volume (30 Days) | ★ 2.8M | 990.3K |
| Earning Date | 05-12-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | N/A | ★ 79.72 |
| EPS | N/A | ★ 1.56 |
| Revenue | $502,076,000.00 | ★ $11,665,000,000.00 |
| Revenue This Year | $89.45 | $5.17 |
| Revenue Next Year | $73.78 | $2.38 |
| P/E Ratio | ★ N/A | $59.70 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $38.57 | $89.21 |
| 52 Week High | $84.94 | $116.62 |
Technical Indicators
Market Signals| Indicator | BBIO | CCK |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 33.86 |
| Support Level | $62.37 | $89.21 |
| Resistance Level | $69.85 | $99.05 |
| Average True Range (ATR) | 2.77 | 2.04 |
| MACD | 0.10 | -0.27 |
| Stochastic Oscillator | 46.43 | 2.29 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About CCK Crown Holdings Inc.
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.